Boston Scientific (BSX) Total Debt (2009 - 2026)

Boston Scientific has disclosed Total Debt across 18 years of filings, most recently posting $12.6 billion for Q2 2026.

• In Q2 2026, Total Debt rose 8.95% year-over-year to $12.6 billion; the TTM figure through Jun 2026 stood at $12.6 billion (up 8.95% YoY), while the FY2025 annual figure was $11.4 billion, up 6.42% from the prior year.
• Total Debt came in at $12.6 billion for Q2 2026 at Boston Scientific, up from $11.0 billion in the prior quarter.
• In the past five years, Total Debt ranged from a high of $12.6 billion in Q2 2026 to a low of $8.6 billion in Q3 2022.
• Average Total Debt over 5 years is $10.2 billion, with a median of $10.6 billion recorded in 2024.
• Year-over-year, Total Debt declined 5.51% in 2022 and grew 22.32% in 2024.
• Over 5 years, Total Debt stood at $8.9 billion in 2022, then advanced by 1.87% to $9.1 billion in 2023, then advanced by 18.06% to $10.7 billion in 2024, then climbed by 6.42% to $11.4 billion in 2025, then increased by 10.39% to $12.6 billion in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $12.6 billion in Q2 2026, $11.0 billion in Q1 2026, and $11.4 billion in Q4 2025.